Influence of antazoline and ketotifen on the anticonvulsant activity of conventional antiepileptics against maximal electroshock in mice

European Neuropsychopharmacology

Volumn 14, Issue 4, 2004, Pages 307-318

  Świa̧der, Mariusz ^a   Wielosz, Marian ^a   Czuczwar, Stanisław J ^a,b  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

Author keywords

Antazoline; Antiepileptic drugs; Drug interactions; Electroshock maximal; Ketotifen; Seizures

Indexed keywords

ANTAZOLINE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; HISTAMINE H1 RECEPTOR ANTAGONIST; KETOTIFEN; LUMINALUM NATRIUM; PHENAZOLINUM; PHENOBARBITAL; PHENYTOIN; VALPROATE MAGNESIUM; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; BLOOD BRAIN BARRIER; BRAIN LEVEL; CONTROLLED STUDY; CONVULSION; DOSE RESPONSE; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG MECHANISM; ELECTRIC SHOCK; EXPERIMENTAL MOUSE; EXPERIMENTAL TEST; LONG TERM MEMORY; MALE; MOTOR COORDINATION; MOTOR PERFORMANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ANIMALS; ANTAZOLINE; ANTICONVULSANTS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; BRAIN; BRAIN CHEMISTRY; CONFIDENCE INTERVALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG SYNERGISM; ELECTROSHOCK; HISTAMINE H1 ANTAGONISTS; KETOTIFEN; MALE; MICE; MOTOR ACTIVITY; PSYCHOMOTOR PERFORMANCE; SEIZURES; TIME FACTORS;

EID: 2442559988     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2003.09.005     Document Type: Article

References (42)

1. Boissier J.-R., Tardy J., Diverres J.-C. Une nouvelle methode simple pour explorer l'action 'tranquilisante': le test de la cheminee. Med. Exp. 3:1960;81-84
2. Borowicz K.K., Kamiński R., Gasior M., Kleinrok Z., Czuczwar S.J. Influence of melatonin upon the protective action of conventional anti-epileptic drugs against maximal electroshock in mice. Eur. Neuropsychopharmacol. 9:1999;185-190
3. Borowicz K.K., Świader M., Kamiński R., Kuźniar H., Kleinrok Z., Czuczwar S.J. Two essential amino acids, L-lysine and L-histidine, in five types of experimental seizures. Pol. J. Pharmacol. 52:2000;345-352
4. Chen Z., Li W.D., Zhu L.J., Shen Y.J., Wei E.Q. Effects of histidine, a precursor of histamine, on pentylenetetrazole-induced seizures in rats. Acta Pharmacol. Sin. 23:2002;361-366
5. Churchull J.A., Gammon G.D. The effect of antihistaminic drugs on convulsive seizures. J. Am. Med. Assoc. 141:1949;18-21
6. Czuczwar S.J., Janusz W., Szczepanik B., Wamil A., Kleinrok Z. Effect of aminophylline upon the protective activity of common antiepileptic drugs and their plasma levels in mice. Neurosci. Res. 6:1989;470-474
7. Deckers C.L.P., Czuczwar S.J., Hekster Y.A., Keyser A., Kubova H., Meinardi H., Patsalos P., Renier W.O., van Rijn C.M. Selection of antiepileptic drug polytherapy based on mechanism of action: the evidence reviewed. Epilepsia. 41:2000;1364-1374
8. Gasior M., Borowicz K., Buszewicz G., Kleinrok Z., Czuczwar S.J. Anticonvulsant activity of phenobarbital and valproate against maximal electroshock in mice during chronic treatment with caffeine and caffeine discontinuation. Epilepsia. 37:1996;262-268
9. Gerald M.C., Richter N.A. Studies on the effects of histaminergic agents on seizure susceptibility in mice. Psychopharmacologia. 46:1976;277-282
10. Goodman L.S., Gilman A. Histamine and antihistaminic agents. Goodman L.S., Gilman A. The Pharmacological Basis of Therapeutic. 2nd ed. 1960;575-599 Macmillan Company, New York
11. 3-receptor antagonists on amygdaloid kindled seizures in rats. Brain Res. Bull. 46:1998;461-465
12. Kamei C. Involvement of central histamine in amygdaloid kindled seizures in rats. Behav. Brain Res. 124:2001;243-250
13. Kamei C., Ishizawa K., Kakinoki H., Fukunaga M. Histaminergic mechanisms in amygdaloid-kindled seizures in rats. Epilepsy Res. 30:1998;187-194
14. 1-antagonists in rats. Brain Res. 887:2000;183-186
15. Kamiński, R.M., Zółkowska, D., Kozicka, M., Kleinrok, Z., Czuczwar, S.J., 2003. L-Histidine is a beneficial adjuvant for antiepileptic drugs against maximal electroshock-induced seizures in mice. Amino Acids, in press.
16. Litchfield J.T., Wilcoxon F. A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 96:1949;99-113
17. 1 receptor blocking. Physiol. Behav. 51:1992;1223-1227
18. 3 receptors and the pharmacology of its ligands. Jpn. J. Psychopharmacol. 15:1995;87-102
19. Onodera K., Tuomisto L., Tacke U., Airaksinan M. Strain differences in regional brain histamine levels between genetically epilepsy-prone and resistant rats. Find. Exp. Clin. Pharmacol. 14:1992;13-16
20. Onodera K., Yamatodani A., Watanabe T., Wada H. Neuropharmacology of histaminergic neuron system in the brain and its relationship with behavioral disorders. Prog. Neurobiol. 41:1994;685-702
21. 1-antagonists. Prog. Neurobiol. 52:1997;145-157
22. Scherkl R., Hashem A., Frey H.H. Histamine in brain - its role in regulation of seizure susceptibility. Epilepsy Res. 10:1991;111-118
23. Scherkl R., Hashem A., Frey H.H. Importance of histamine for seizure susceptibility. Agents Actions Suppl. 33:1991;85-89
24. Świader M., Kalisz A., Porebiak J., Kleinrok Z., Czuczwar S.J. Influence of antazoline on the anticonvulsant activity of conventional antiepileptic drugs against maximal electroshock-induced seizures in mice. Pol. J. Pharmacol. 51:1999;104
25. 1 receptor antagonists on the anticonvulsant activity of antiepileptic drugs. Pol. J. Pharmacol. 53:2001;93-96
26. Tuomisto L., Tacke U. Is histamine an anticonvulsive inhibitory transmitter? Neuropharmacology. 25:1986;955-958
27. Tuomisto J., Tuomisto L. Effects of histamine and histamine antagonists on the uptake and release of catecholamines and 5-HT in brain synaptosomes. Med. Biol. 58:1980;33-37
28. Venault P., Chapouthier P., de Carvallo L.P., Simiand J., Morre M., Dodd R.H., Roissier J. Benzodiazepines impair and beta-carbolines enhance performance in learning and memory tasks. Nature. 321:1986;864-866
29. 3 receptor antagonist, protects against PTZ-induced seizures in mice. Life Sci. 66:2000;297-301
30. 3-receptor ligands: a possible role in the mechanism and management of epilepsy. Pharmacol. Biochem. Behav. 68:2001;735-741
31. Wlaź P., Rolinski Z., Kleinrok Z., Czuczwar S.J. Anticonvulsant activity of carbamazepine and diphenylhydantoin against maximal electroshock in mice chronically treated with aminophylline. J. Neural Transm. 89:1992;41-48
32. Wlaź P., Rolinski Z., Kleinrok Z., Czuczwar S.J. Influence of chronic aminophylline on the anticonvulsant efficacy of phenobarbital and valproate in mice. Epilepsia. 34:1993;385-389
33. Wyngarden J.B., Seevers M.H. The toxic effects of antihistaminic drugs. J. Am. Med. Assoc. 145:1951;277-282
34. 1 antagonist. Neuropediatrics. 29:1998;320-321
35. Yokoyama H., Iinuma K. Histamine and seizures - implications for the treatment of epilepsy. CNS Drugs. 5:1996;321-330
36. Yokoyama H., Onodera K., Maeyama K., Yanai K., Iinuma K., Tuomisto L., Watanabe T. Histamine levels and clonic convulsions of electrically-induced seizure in mice: the effects of alpha-fluoromethylhistidine and metoprine. Naunyn-Schmiedeberg's Arch. Pharmacol. 346:1992;40-45
37. 1 antagonist, confirmed by the use of D-chlorpheniramine with monitoring electroencephalography. Methods Find. Exp. Clin. Pharmacol. 15:1993;183-188
38. 3 receptor antagonist, on electrically induced convulsions in mice. Eur. J. Pharmacol. 234:1993;129-133
39. 1-antagonists on electrically-induced seizure in developing mice. Psychopharmacology. 112:1993;199-203
40. 1 agonist, decreases seizure susceptibility in mice. Pharmacol. Biochem. Behav. 47:1994;503-507
41. 1-antagonists promote the development of amygdala kindling in rats. Neurosci. Lett. 217:1996;194-196
42. Yoshida M., Noguchi E., Tsuru N. Lack of substantial effect of the H(3)-antagonist thioperamide and of the non-selective mixed H(3)-antagonist/H(1) -agonist betahistine on amygdaloid kindled seizures. Epilepsy Res. 40:2000;141-145